Finally TET2−/− AML mice model and/or clinical patients‘ samples with TET2 mutation also can be treated with PARPis to observe the treatment's effect and further explore the mechanism of TET2 in regulating genomic stability. Here, TET2 is linked to acute myeloid leukemia.